1. Oncogenic RAS-induced CK1α drives nuclear FOXO proteolysis
   F Zhang et al, 2017, Oncogene CrossRef
2. Targeting Cell Cycle Proteins in Brain Cancer
   Isabelle Ferry et al, 2018 CrossRef
3. Marizomib activity as a single agent in malignant gliomas: ability to cross the blood-brain barrier.
   Kaijun Di et al, 2016, Neuro Oncol CrossRef
4. Novel phosphatidylinositol 3-kinase inhibitor BKM120 enhances the sensitivity of multiple myeloma to bortezomib and overcomes resistance
   Wenjun Yu et al, 2017, Leukemia & Lymphoma CrossRef
5. Recent advances in the use of PI3K inhibitors for glioblastoma multiforme: current preclinical and clinical development
   Hua-fu Zhao et al, 2017, Mol Cancer CrossRef
6. Relevance of Translation Initiation in Diffuse Glioma Biology and its Therapeutic Potential
   Digregorio Marina et al, 2019, Cells CrossRef
7. Clinically Actionable Insights into Initial and Matched Recurrent Glioblastomas to Inform Novel Treatment Approaches
   H. P. Ellis et al, 2019, Journal of Oncology CrossRef
8. Axitinib induces senescence-associated cell death and necrosis in glioma cell lines: The proteasome inhibitor, bortezomib, potentiates axitinib-induced cytotoxicity in a p21(Waf/Cip1) dependent manner
   Maria Beatrice Morelli et al, 2017, Oncotarget CrossRef
9. Inhibition of the PI3K/AKT signaling pathway sensitizes diffuse large B‑cell lymphoma cells to treatment with proteasome inhibitors via suppression of BAG3
   Ting Yuan et al, 2019, Oncol Lett CrossRef
10. 1,3,5-Triazine-azole Hybrids and their Anticancer Activity
    Hua Guo et al, 2020, CTMC CrossRef
11. Targeting RTK-PI3K-mTOR Axis in Gliomas: An Update
    Mayra Colardo et al, 2021, IJMS CrossRef
12. Wnt and PI3K/Akt/mTOR Survival Pathways as Therapeutic Targets in Glioblastoma
    Amir Barzegar Behrooz et al, 2022, IJMS CrossRef
13. Proteasome Inhibitors against Glioblastoma—Overview of Molecular Mechanisms of Cytotoxicity, Progress in Clinical Trials, and Perspective for Use in Personalized Medicine
    Agata Gozdz, 2023, Current Oncology CrossRef
14. Enhanced delivery of PI3K inhibitor to glioblastoma via folic acid-functionalized biomimetic nanoparticles
    Zixiang Yu et al, 2025, Materials Letters CrossRef